Objective Although important advances in understanding the aetiology and pathogenesis of inflammatory bowel disease (IBD) have been made, many questions remain unanswered. As the most recent data available on the incidence of IBD in Germany were collected about 15 years ago, we set up a new population-based cohort to determine current incidence data for a defined region in Germany and to establish a basic cohort for prospective follow-up.
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study Objective Although important advances in understanding the aetiology and pathogenesis of inflammatory bowel disease (IBD) have been made, many questions remain unanswered. As the most recent data available on the incidence of IBD in Germany were collected about 15 years ago, we set up a new population-based cohort to determine current incidence data for a defined region in Germany and to establish a basic cohort for prospective follow-up.
Methods All patients living in the region of Oberpfalz newly diagnosed with IBD between 1 January 2004 and 31 December 2006 were included in this study by setting up a network of reporting clinicians and general practitioners in hospitals as well as in private practices. Demographic and clinical characteristics such as age at first diagnosis, localization of the disease, extraintestinal manifestations or family history on IBD were documented.
Introduction
The aetiology of inflammatory bowel diseases (IBD) is multifactorial. Genetic factors seem to increase susceptibility to IBD, which might be influenced by immunological mechanisms and environmental factors [1] . Although there have been important advances in understanding the aetiology and pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC), many questions remain unanswered. A wealth of epidemiological studies on incidence, prevalence and demographic factors of patients with IBD have been performed in different countries to provide possible clues to the aetiology of IBD [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Results of these population-based studies show great variability on the incidence of IBD with highest rates in northern countries of Europe and in North America [17] . In addition, increasing incidence rates of IBD have been reported recently from different countries [18] [19] [20] . In other regions, the incidence seems to have stabilized during the last years [21] .
Few papers have been published presenting populationbased data from Germany. A retrospective study from Marburg described patients diagnosed with IBD between 1962 and 1975 [22] . Studies from Tübingen included both retrospective and prospective data in cooperation with general practitioners of the region [23] . The most recent incidence rates available from Germany were published in collaboration with the European Collaborative Study on IBD, which so far represents the largest prospective incidence cohort worldwide [14, 24, 25] . The incidence rate in Essen and Mülheim (participating centres of European Collaborative Study on IBD in Germany) was calculated as approximately 5/10 5 cases per year for CD [25] . This is in accordance with data from similar countries. In contrast, the incidence of UC in Germany was low with 3.5/10 5 cases per year (excluding proctitis) [24] . Prospective follow-up data are not available from any of these cohorts.
Therefore, we established a cohort with the aim to provide a basis for prospective analyses on the prognosis and immunological changes over time. Furthermore, we want to determine current incidence data for a defined region in Germany.
Materials and methods

Population
The region of Oberpfalz (upper Palatine) is located in Bavaria (Germany) with a population of 1 089 000 inhabitants (Fig. 1a) , bordering the Czech Republic in the north and east and the river Danube in the south. This rural, but well-defined, geographical area is divided into 10 districts and free cities (Fig. 1b) . Migration rates in this area are low (4.7% in 2005).
The city of Regensburg represents the regional capital with 129 929 inhabitants (30 June 2006) . In total, in the region of Oberpfalz, 46 practitioners offer endoscopy in addition to 10 endoscopy facilities located at the hospitals within the area. For complete ascertainment of new cases, we set up a network of reporting clinicians and general practitioners including internists, gastroenterologists, surgeons and paediatricians in hospitals as well as in private practice. All cooperating physicians were regularly contacted to encourage active, prospective reporting of incident cases. Computer-based discharge registries were searched using text searches for CD, UC and IBD to identify all patients with the diagnosis of IBD to make sure all incident cases were reported.
Inclusion criteria
Cases were included in the study if they met the following criteria: results were reviewed by a gastroenterologist before the case was finally included.
Exclusion criteria
Cases with chronic inflammatory disease other than IBD/ infection, such as positive test from bacteriological or virological culture of faeces with evidence for pathogenic gut bacteria (excluding Myobacterium avium), findings of parasites, cysts and eggs, genetic screening of microbes in faeces, were excluded. Particular attention was payed to patients who have spent time in epidemic areas for Entamoeba histolytica and patients undergoing treatment with antibiotics or immunosuppressants. Confirmation of eosinophilic colitis, Bechet's disease, secondary inflammation, solitary ulcer or coeliac disease was used as exclusion criteria as well. Cases with a possible or likely, but yet unconfirmed diagnosis of IBD were not included in the analyses, but followed up separately for further review (not reported).
Data collection
Recruitment started on 1 January 2004 and data up to 31 December 2006 are reported. For each patient, a standardized data form was completed at the time of first diagnosis by the attending physician, which included demographic data (date of birth, sex, place of residence), onset of symptoms, date of diagnosis, extent of disease, familial occurrence of IBD, extraintestinal manifestations and actual laboratory tests. After informed consent, all patients were then contacted by the study centre personnel. Information on risk factor exposure, as well as general and disease-specific health-related quality of life and sociodemographic variables were collected using pretested standardized questionnaires.
The Vienna classification [26] was applied to describe clinical patient subgroups in CD with L1: disease limited to the terminal ileum with or without spill into coecum, L2: disease location at any position between coecum and rectum without involvement of the small bowel or upper gastrointestinal tract, L3: involvement of the terminal ileum and the colon and L4: any disease location proximal to the terminal ileum. The extent of UC was defined as proctitis, left-sided (to the splenic flexure), subtotal (beyond the splenic flexure, but not the total colon) and total colitis.
Statistics
Statistical analyses were performed using SPSS software (SPSS for windows 12.0, Chicago, Illinois, USA). Data are given as numbers, percentages, medians and range. Exploratory analyses were performed using w 2 test (or t tests for continuous variables) based on a 95% confidence interval (two-sided).
Incidence rates were calculated using population data by age and sex for the catchment area as supplied by the Department of Statistics of Bavaria [27] and subsequently converted to age-standardized incidence rates based on the European standard population. The 95% confidence intervals (CIs) for incidence rates were calculated assuming a Poisson distribution [28] .
Results
During the study period from 1 January 2004 to 31 December 2006, 286 newly diagnosed patients with IBD were reported. In total, 168 patients with CD, 105 patients suffering from UC and 13 patients with indeterminate colitis were documented. Median age at first diagnosis of all patients was 33 years (range: 1-83.4 years). About 55% of CD patients, 49% of UC patients and 54% of indeterminate colitis patients were women. Disease-specific demographic characteristics are provided in Table 1 .
Incidence
The mean annual crude incidence rate for IBD in this region was 10.5/10 5 (95% CI: 8.7-11.1). Crude incidence for CD was calculated with 6.1/10 5 (95% CI: 5.2-7.1) and for UC with 3.9/10 5 (95% CI: 3.2-4.7). The age-related comparison of incidence in CD and UC is shown in Fig. 2 .
Age-standardized incidence rates were 11.0/10 5 (95% CI: 9.1-11.6) for IBD, 6.6/10 5 (95% CI: 5.6-7.7) for CD and 3.9/10 5 (95% CI: 3.2-4.7) for UC. Age-specific incidence rates by sex are given in Fig. 3 .
Age-specific incidence peaked in the age group of 16-25 years in both CD and UC, as expected. The peak was more pronounced in CD (18.5/10 5 ) as compared with UC (6.5/10 5 ). The median onset of disease symptoms before first diagnosis was 60 days in all IBD patients. In patients with CD, the median time until first diagnosis was 90 days, which was slightly longer than in patients with UC, whose time to diagnosis was 60 days. No evidence was obtained for variation in seasonal onset of symptoms or first diagnosis.
Extent and course of disease
On the basis of the Vienna classification, the most frequent subtypes were patients with a nonstructuring and nonpenetrating inflammatory course, diagnosed before the age of 40 years, with inflammation either of the small bowel only (classification code: A1L1B1, n = 28; (Fig. 4) .
The course of the disease was reported to be B1 (nonstricturing, nonpenetrating, 113 patients, 67.3%) most frequently, in seven patients a stricture was found at first diagnosis (B2, 4.2%) and in 30 patients (17.9%) the behaviour was penetrating (B3). In patients classified as A1 (age below 40 years), a penetrating course of the disease was found in 26 patients (15.5%) versus four patients (2.4%) aged above 40 years at the time of first diagnosis (P = 0.07).
Among patients with UC, 30 patients were reported having proctitis (28.6%), another 30 patients had leftsided colitis (28.6%), six patients had subtotal colitis (5.7%) and 33 patients were diagnosed as having pancolitis (31.4%) (Fig. 5) .
Surgical procedures including treatment of fistulas became necessary in 24 patients (8.4%) around the time of diagnosis ( ± 3 months). In patients with CD, eight patients (4.7% of patients with CD) underwent resection Crohn`s disease Ulcerative colitis
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Age-specific inflammatory bowel disease incidence by sex. of the terminal ileum, six of them at the time of first diagnosis and two other patients 1 and 2 months after first diagnosis. Three patients (1.8% of patients with CD) had partial resection of the large bowel and one patient (0.5%) had undergone partial resection of small bowel at the time of first diagnosis and another patient 1 month after first diagnosis. In 11 patients (6.5% of patients with CD), surgical treatment of fistulas or abscesses was performed (in four patients before first diagnosis, in one patient at first diagnosis, in three patients 2-4 months after first diagnosis and in three patients the exact date was not known). In patients with UC, only two surgical procedures became necessary, one patient had proctocolectomy at the time of first diagnosis and in another patient parts of large bowel had to be resected.
Family history, extraintestinal manifestations and smoking status
As shown in Table 1 , 30 patients (10.5%) reported a family history positive of IBD. This was more frequent in patients with CD than with UC (21 vs. 9 cases, P = 0.4). In 20 of these 30 patients (66%), more detailed information was available about the IBD of the affected relative. Eleven patients had relatives with CD, nine relatives were diagnosed with UC. In 21 patients, a first-degree relative was affected (70%, father of the case: n = 8, mother of the case: n = 8, brother of the case: n = 2, sister of the case: n = 1, daughter of the case: n = 2). Fifteen relatives were reported having the same diagnosis as the case (50%), five relatives (17%) had another type of IBD.
The frequency of extraintestinal manifestations is shown in Table 2 . Involvement of the joints was the most common manifestation. Patients with CD were slightly more often affected by extraintestinal manifestations, in general, than patients with UC (26.8 vs. 21.9%, P = 0.39).
Of all 286 patients, 106 patients (37%) reported current or former smoking, the rest never smoked before. At the time of first diagnosis, 16.1% of the patients with CD (27 cases) were current smokers compared with 7.5% of patients with UC (12 cases). Of note, 30.5% of patients with UC (32 cases) reported they had previously smoked compared with 20.8% of patients with CD (35 cases).
Discussion
As the most recent data on the incidence of IBD in Germany were collected between 1991 and 1995, one aim of this study was to investigate the current situation in a defined region. The reference area is particularly suitable for valid assessment of incidence data, as it is traditionally a very low migration region. The area borders the Czech Republic in the north and east and the river Danube in the south, so the catchment area is very well defined. Exact numbers of inhabitants are available from regional authorities. Completeness of case ascertainment was furthered by the successful establishment of a network of reporting clinicians and general practitioners from all over the region, including internists, gastroenterologists, surgeons and paediatricians in hospitals and also private practices.
The mean annual incidence rate for CD with 6.6/10 5 per year was rather high compared with the estimated number of 5/10 5 per year, whereas the incidence for UC with 3.9/10 5 was less than expected. In most population-based studies, the incidence of UC is described to be higher than incidence of CD [5, 10, 12, 14, 20, 21, 29] with incidence rates for UC up to 24.3/10 5 in Reykjavik (Iceland) or 16.6/10 5 in Crete [14] . Only few population-based studies found higher incidence rates in CD as compared with UC. For example, a high incidence of CD was reported from Northern France [6] . Studies from Canada showed the highest incidence for CD reported at that time [16, 18] . In these studies, incidence rates were calculated retrospectively using health databases. Recently, population-based data from Croatia also showed more incident cases for CD than for UC [13] . Furthermore, Gearry et al. [3] found high incidence rates for CD in New Zealand with 16.5/10 5 , which represents one of only two population-based studies from the southern hemisphere. Of note, this incidence was calculated only for the first year of prospective patient recruitment, which is indicative of bias owing to raised awareness on the basis of the commencing recruitment (Table 3) . However, until now, there is no convincing explanation for these geographical differences in the incidence of both diseases.
With findings from Copenhagen and Croatia, two welldefined population-based cohorts have been described, which are at similar distance from the region of Oberpfalz (about 1000 km to Croatia, 1100 km to Copenhagen), whereas the incidence rates in the region of Oberpfalz are similar to results from Croatia [13] , the latest data from Copenhagen show much higher incidences with predominance for UC [20] . Although these findings are likely to be caused by demographic characteristics such as racial and ethnic influences, they also strongly suggest the presence and importance of environmental factors in the pathogenesis of IBD.
In contrast to the higher incidence of CU in the 'northern' cohort of Copenhagen compared with the data from the 'southern' cohorts of Oberpfalz and Croatia, recent findings from France show a north-south gradient for CD with lower incidences in southern parts of France [33] . As possible reasons for the higher incidence of CD in the northern areas, the authors discuss a more 'prudent diet' with fruits, vegetable, fish and olive oil preferred in Southern France, compared with diet habits with more consumption of sausage, butter and beer in the north, which might have influences on the different incidence. Similar to Northern France, most people of the region of Oberpfalz prefer a diet with meat, sausages and beer, which might lead us to corroborate this hypothesis. However, in the studied region of Croatia, people are adopted to the mediterrean diet, which is in contrast to the possible explanation mentioned above. As the consumption of beer is different in these regions, there might be a possible effect on the incidence rates caused by this environmental factor.
In another approach to explain the differences of higher incidence of CD in some areas, the incidence of UC is suggested to be stabilized during the last decades, whereas the incidence of CD tended to increase [30] . Furthermore, better diagnostic tools, such as magnetic resonanceenteroclysis and capsule endoscopy, are discussed to increase incidence rates in CD in the later cohorts [20, 31] .
In contrast to these findings, data from Germany from 1970 to 1984 from Tübingen and Mühlheim/Essen from 1980 to 1995 showed a higher incidence and prevalence of CD in these regions, hence this disease might be more common in the studied parts of Germany [23] [24] [25] . In addition, as our number of cases with proctosigmoiditis (28%) in patients with UC is highly comparable to previous reports [10, 20] , we might not underestimate the incidence of UC by missing mild or moderate courses of the disease.
With regard to sex relationship, we found a preponderance for women in CD, whereas in UC the man to woman ratio was close to 1. This distribution confirms findings in some previous studies [4, 14, 34] . Median age at first diagnosis was similar to findings published elsewhere [15, 20] with 29 years for patients with CD and about 10 years later (39.5 years) for patients with UC. We found the expected peak incidence in the age interval of 16-25 years in both, CD and UC, but the height of the peak in patients with UC was rather low in contrast to 18.5/10 5 new cases of CD at that age. With increasing age beyond the peak, the incidence in CD is decreasing rapidly, whereas incidences in UC remain stable in later decades of life. In accordance with the latest findings from Copenhagen [20] , we did not register a second peak of incidence later in life, neither in CD nor in UC, as described in other studies [10, 11, 34, 35] .
During the last decades, time from onset of symptoms to first diagnoses decreased steadily. Previously, the median delay for CD was 2.2 years [30] , more recent findings describe a median delay of 4.5 months for UC and 8.3 months for CD [20] . With a median delay of 60 days for UC and 90 days for CD, diagnosis in our series was made even more rapidly. As previously suggested, improvement of diagnostic tools and an increasing awareness of IBD might be an explanation for this development.
The extent of the disease in UC was comparable to previous studies, whereas in patients with CD a relatively higher number of patients (14%) showed an involvement of the upper gastrointestinal tract. This is in contrast to other studies that described an affection of the upper GI tract in only 6-7% of patients [13, 20, 36] .
Regarding surgery rates, family history and smoking status, our findings are comparable with previous studies, reporting of low surgery rates at or shortly after first diagnosis [20] and a slightly more frequent family history of IBD in patients with CD [17, 37] , which was not statistically significant in our series. In addition, with respect to the occurence of extraintestinal manifestations similar numbers were found in previous reports with observation of at least one extraintestinal manifestation in 26.8 and 21.9% patients, respectively [38] . As reported previously, the most commonly involved organs were joints, eyes and skin, whereas no primary sclerosing cholangitis was found at all in our cohort.
In conclusion, this present prospective, population-based study from the region of Oberpfalz showed a nearly stable incidence compared with the last data available from Germany. Of note, that the incidence of CD was found to be higher than the incidence of UC in this region, which supports the importance of environmental factors in the aetiology and pathogenesis of these diseases.
As the clinical characteristics of our patients are very similar to those described in previous studies, this cohort [10, 11] 1990-1993 5.8 13.6 Copenhagen [30, 31] 1980-1987 4.1 9.2 [20] 2003-2005 8.6 13.4 Olmsted county [15, 32] 1984-1993 6.9 8.3 [21] 1990-2000 7.9 8.8 EC-IBD (German center) [14] Oct 1991-Sept 1993 3.5 4.3 Manitoba [4] 1989-1994 14.6 14.3 Northern France [6] 1988 with a prospective follow-up provides a highly favourable basis for further studies on aetiologic factors in IBD.
